e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
New drugs in respiratory medicine
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The anti-inflammatory effects of PF03715455 and roflumilast on both cellular and tissue inflammation in a mouse model of COPD
V. Russell, M. Foster, P. Woodman, A. Young (Slough, United Kingdom)
Source:
Annual Congress 2013 –New drugs in respiratory medicine
Session:
New drugs in respiratory medicine
Session type:
Poster Discussion
Number:
1586
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Russell, M. Foster, P. Woodman, A. Young (Slough, United Kingdom). The anti-inflammatory effects of PF03715455 and roflumilast on both cellular and tissue inflammation in a mouse model of COPD. Eur Respir J 2013; 42: Suppl. 57, 1586
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
The effects of intra-nasally administered anti-inflammatory compounds in a mouse model of acute COPD exacerbations
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013
The anti-inflammatory effects of eucalyptol in a mouse model of LPS-induced pulmonary inflammation are mediated by TRPM8
Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models
Year: 2016
CHI-91040, a novel inhaled p38α inhibitor, counteracts lung inflammation induced by IL-1β in the rat
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
The effects of clinically relevant reference agents in a mouse model of severe asthma
Source: International Congress 2015 – Advances in the future treatment of severe asthma
Year: 2015
An antedrug of the CXCL12 neutraligand blocks experimental allergic asthma without systemic effect in the mouse
Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD
Year: 2013
Nicotine impairs inflammation-induced airway relaxation in a in vitro murine model of asthma
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
Anti-inflammatory effects of resveratrol analogues in cellular models of airway inflammation
Source: International Congress 2015 – Advances in the future treatment of COPD
Year: 2015
Adipose derived stem cells ameliorate airway inflammation in mouse models of asthma
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
Effect of the combination of doxofylline and montelukast on LPS-induced leukocyte migration to the lung
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
In vivo efficacy of CHF6001, an inhaled PDE4 inhibitor with a wide therapeutic window
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
Antioxidant effects of bisphosphonates in smoking- induced lung injury in rat model
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015
Pharmacological profile and efficacy of GLPG1690, a novel ATX inhibitor for COPD treatment
Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Year: 2015
Prediction of human lung PK for AZD7624, an inhaled P38 inhibitor for the treatment of COPD
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015
PI3Kδ inhibition confer efficacy in experimental models of allergic airway inflammation
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015
Mepenzolate bromide displays beneficial effects in a mouse model of chronic obstructive pulmonary disease
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
Assesment of the effects of tocilizumab, adalimumab and steroid in LPS induced acute lung inflammation
Source: International Congress 2016 – Airway response to infection
Year: 2016
A combination of thyme and ivy exerts potent anti-inflammatory and mucus-normalizing activity
in vivo
and inhibits 5-LO and PDE4
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
Aerobic training reverses airway inflammation by increasing the expression of anti-inflammatory cytokines by peribronchial cells but not by skeletal muscle
Source: International Congress 2015 – Inflammation and remodelling in lung disease
Year: 2015
Ciclesonide and tiotropium synergistically inhibit airway eosinophilia in a guinea pig model of chronic asthma
Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management
Year: 2013
Polyphenolic compounds and experimentally induced allergic asthma
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept